Related Experiment Video
Updated: Sep 12, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Chronic type II interferon promotes tumor growth through mitochondrial RNA-induced type I interferon and
Melissa A Johnson1,2, Siva Karthik Varanasi1, Kailash Chandra Mangalhara1
1Salk Institute for Biological Studies, La Jolla, CA, USA.
Abstract:
Interferons (IFNs) are proinflammatory cytokines that promote immune cell engagement to eliminate malignant cells. Paradoxically, chronic interferon signaling can also activate anti-inflammatory mechanisms that allow cancer cells to evade the immune system. In this study, we sought to determine the cellular mechanisms underlying this switch from antitumorigenic to protumorigenic interferon activity. We show that chronic type II interferon (IFN-II) exposure distinctively induced tumor growth by activating a type I interferon (IFN-I) response mediated by release of double-stranded mitochondrial RNA (ds-mtRNA) into the cytoplasm. This IFN-I signal synergized with IFN-II to enhance tumor growth by increasing immunosuppressive prostaglandin E2 (PGE2) synthesis through increased cyclooxygenase 2 expression. Elimination of PGE2 synthesis in immunotherapy-resistant melanoma cells restored their responsiveness to anti-PD1 treatment, indicating that this covert mtRNA-IFN-prostaglandin pathway could be a therapeutic target to combat immunotherapy resistance.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Type I Diabetes II: Pathophysiology
Cirrhosis II: Pathophysiology
Tumor Immunotherapy
Mechanisms of Retrovirus-induced Cancers
